Scopus BioPharma Inc.
SCPS · OTC
12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| R&D Expenses | $2,682 | $15,023 | $7,424 | $463 |
| G&A Expenses | $9,033 | $12,611 | $2,732 | $2,227 |
| SG&A Expenses | $9,033 | $12,611 | $2,732 | $2,227 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $11,715 | $27,635 | $10,156 | $2,690 |
| Operating Income | -$11,715 | -$27,635 | -$10,156 | -$2,690 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $0 | $681 | -$706 | $0 |
| Pre-Tax Income | -$11,715 | -$26,953 | -$10,862 | -$2,690 |
| Tax Expense | -$105 | $775 | $706 | $0 |
| Net Income | -$11,610 | -$27,728 | -$11,569 | -$2,690 |
| % Margin | – | – | – | – |
| EPS | -0.55 | -1.61 | -0.87 | -0.18 |
| % Growth | 65.8% | -85.1% | -383.3% | – |
| EPS Diluted | -0.55 | -1.61 | -0.87 | -0.18 |
| Weighted Avg Shares Out | 21,094 | 17,252 | 13,363 | 14,976 |
| Weighted Avg Shares Out Dil | 21,094 | 17,252 | 13,363 | 14,976 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $775 | $706 | $0 |
| Depreciation & Amortization | $2 | $2 | $1 | $1 |
| EBITDA | -$11,713 | -$26,177 | -$10,154 | -$2,689 |
| % Margin | – | – | – | – |